A detailed history of Louisiana State Employees Retirement System transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 52,800 shares of BMRN stock, worth $3.35 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
52,800
Previous 53,700 1.68%
Holding current value
$3.35 Million
Previous $4.42 Million 16.06%
% of portfolio
0.07%
Previous 0.09%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$69.02 - $93.84 $62,118 - $84,456
-900 Reduced 1.68%
52,800 $3.71 Million
Q2 2024

Jul 24, 2024

BUY
$74.43 - $92.22 $4 Million - $4.95 Million
53,700 New
53,700 $4.42 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Louisiana State Employees Retirement System Portfolio

Follow Louisiana State Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.